|4Nov 3, 4:16 PM ET

FROM STEPHEN 4

4 · EYEGATE PHARMACEUTICALS INC · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-02
FROM STEPHEN
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2021-11-02$1.98/sh250$49568,292 total
Footnotes (1)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021.

Documents

1 file
  • 4
    tm2131814-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT